On January 22, 2016, it was reported that the Federal Trade Commission has opened an investigation into Turing Pharmaceuticals Inc.’s decision last year to hike the price of the life-saving drug Daraprim by more than 5000 percent. The New York Attorney General opened an investigation last October after Turing raised the…
Updated: